CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Study of the Combination of Lenalidomide (Revlimid®) With Two Different Dose Levels of Short Term Administration of Recombinant Human Stem Cell Factor (rhSCF; Ancestim) for Myelodysplasia.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00434239
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:23.623197+00:00
Published At: 2013-01-10T00:00:00+00:00
Record Updated At: 2013-01-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myelodysplasia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-01-10"
protocolSection.identificationModule.nctId: "NCT00434239"
protocolSection.identificationModule.officialTitle: "A Pilot Study of the Combination of Lenalidomide (Revlimid\u00ae) With Two Different Dose Levels of Short Term Administration of Recombinant Human Stem Cell Factor (rhSCF; Ancestim) for Myelodysplasia."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.